Comment on 'Toxicities associated with immune checkpoint inhibitors: A systematic study'

被引：0

作者：

Hosseini, Mohammad-Salar ^{[1
,2
,4
]}

Jahanshahlou, Farid ^{[3
]}

机构：

[1] Tabriz Univ Med Sci, Hematol & Oncol Res Ctr, Tabriz, Iran

[2] Tabriz Univ Med Sci, Iranian EBM Ctr A Joanna Briggs Inst, Res Ctr Evidence Based Med, Ctr Excellence, Tabriz, Iran

[3] Tabriz Univ Med Sci, Aging Res Inst, Tabriz, Iran

[4] Tabriz Univ Med Sci, Res Ctr Evidence Based Med, Golgasht St, Tabriz 516615731, East Azerbaijan, Iran

来源：

INTERNATIONAL JOURNAL OF SURGERY | 2023年 / 109卷 / 08期

关键词：

D O I：

10.1097/JS9.0000000000000478

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：2555 / 2556

页数：2

共 4 条

[1] Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study [J].

Burtness, Barbara ;

Harrington, Kevin J. ;

Greil, Richard ;

Soulieres, Denis ;

Tahara, Makoto ;

de Castro, Gilberto, Jr. ;

Psyrri, Amanda ;

Baste, Neus ;

Neupane, Prakash ;

Bratland, Ase ;

Fuereder, Thorsten ;

Hughes, Brett G. M. ;

Mesia, Ricard ;

Ngamphaiboon, Nuttapong ;

Rordorf, Tamara ;

Ishak, Wan Zamaniah Wan ;

Hong, Ruey-Long ;

Mendoza, Rene Gonzalez ;

Roy, Ananya ;

Zhang, Yayan ;

Gumuscu, Burak ;

Cheng, Jonathan D. ;

Jin, Fan ;

Rischin, Danny .

LANCET, 2019, 394 (10212) :1915-1928

[2] Toxicities associated with immune checkpoint inhibitors: a systematic study [J].

Kong, Xiangyi ;

Chen, Li ;

Su, Zhaohui ;

Sullivan, Ryan J. ;

Blum, Steven M. ;

Qi, Zhihong ;

Liu, Yulu ;

Huo, Yujia ;

Fang, Yi ;

Zhang, Lin ;

Gao, Jidong ;

Wang, Jing .

INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (06) :1753-1768

[3]

Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.i4086, 10.1136/bmj.b2700, 10.1016/j.ijsu.2010.07.299, 10.1186/2046-4053-4-1, 10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]

[4] Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial [J].

Mok, Tony S. K. ;

Wu, Yi-Long ;

Kudaba, Iveta ;

Kowalski, Dariusz M. ;

Cho, Byoung Chul ;

Turna, Hande Z. ;

Castro, Gilberto, Jr. ;

Srimuninnimit, Vichien ;

Laktionov, Konstantin K. ;

Bondarenko, Igor ;

Kubota, Kaoru ;

Lubiniecki, Gregory M. ;

Zhang, Jin ;

Kush, Debra ;

Lopes, Gilberto .

LANCET, 2019, 393 (10183) :1819-1830

← 1 →